High-cost drug approval system stays with Blueteq for CTMUHB
- NHS Wales Shared Services Partnership
- Wales
- Direct
- 26 April 2026 to 25 April 2028
NHS Wales Shared Services Partnership awarded Blueteq Ltd a contract to keep running the Medicines Optimisation approval system for high-cost drugs at CTMUHB.
The electronic system gives clinical and financial governance over these drugs, so that their use follows the recommendations of NICE and AWMSG. Blueteq, a small business, was already delivering the system for CTMUHB.
The £88,000 contract was awarded directly in February 2026 and runs for two years, to April 2028.
Contract ends April 2028
- What
- Pharmacy and electronic prescribing system
- Supplier
- Blueteq Ltd
- Value
- £88,000
- How it was bought
- Direct
- Dates and next
- Apr 2026 to Apr 2028